Mesa Laboratories, Inc. (MLAB)
127.29
-0.22
(-0.17%)
USD |
NASDAQ |
Oct 12, 10:17
Mesa Laboratories Cash from Investing (Quarterly) : -0.559M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.559M |
| March 31, 2026 | -0.417M |
| December 31, 2025 | -0.732M |
| September 30, 2025 | -1.092M |
| June 30, 2025 | -1.009M |
| March 31, 2025 | -1.007M |
| December 31, 2024 | -0.813M |
| September 30, 2024 | -1.788M |
| June 30, 2024 | -0.891M |
| March 31, 2024 | 0.426M |
| December 31, 2023 | -80.83M |
| September 30, 2023 | -0.634M |
| June 30, 2023 | -0.27M |
| March 31, 2023 | -1.026M |
| December 31, 2022 | -6.604M |
| September 30, 2022 | -1.639M |
| June 30, 2022 | -0.225M |
| March 31, 2022 | -0.782M |
| December 31, 2021 | -302.85M |
| September 30, 2021 | -0.938M |
| June 30, 2021 | -0.653M |
| March 31, 2021 | -1.038M |
| December 31, 2020 | -0.247M |
| September 30, 2020 | -0.491M |
| June 30, 2020 | -0.216M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.548M |
| December 31, 2019 | -181.94M |
| September 30, 2019 | -0.317M |
| June 30, 2019 | -2.781M |
| March 31, 2019 | -0.055M |
| December 31, 2018 | -5.198M |
| September 30, 2018 | 1.673M |
| June 30, 2018 | -0.30M |
| March 31, 2018 | -0.344M |
| December 31, 2017 | -15.90M |
| September 30, 2017 | 0.626M |
| June 30, 2017 | -1.567M |
| March 31, 2017 | -2.42M |
| December 31, 2016 | -5.915M |
| September 30, 2016 | -4.049M |
| June 30, 2016 | -6.021M |
| March 31, 2016 | -2.35M |
| December 31, 2015 | -3.768M |
| September 30, 2015 | -24.05M |
| June 30, 2015 | -1.675M |
| March 31, 2015 | -2.109M |
| December 31, 2014 | -6.537M |
| September 30, 2014 | -0.515M |
| June 30, 2014 | -14.21M |
| March 31, 2014 | -0.233M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Agilent Technologies, Inc. | -1.032B |
| Bio-Rad Laboratories, Inc. | -66.70M |
| Bruker Corp. | -25.30M |
| Danaher Corp. | -10.15B |
| Harvard Bioscience, Inc. | -0.916M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 14.74M |
| Cash from Financing (Quarterly) | -10.50M |
| Free Cash Flow | 52.87M |
| Free Cash Flow Per Share (Quarterly) | 2.463 |
| Free Cash Flow to Equity (Quarterly) | 21.66M |
| Free Cash Flow to Firm (Quarterly) | 15.71M |
| Free Cash Flow Yield | 7.42% |